Skip to main content

Stryker Corporation (SYK)

NYSE: SYK · IEX Real-Time Price · USD
246.87 -0.53 (-0.21%)
Dec 3, 2021 4:03 PM EST - Market closed
Market Cap93.13B
Revenue (ttm)16.67B
Net Income (ttm)1.90B
Shares Out377.24M
EPS (ttm)4.97
PE Ratio49.69
Forward PE23.20
Dividend$2.52 (1.02%)
Ex-Dividend DateSep 29, 2021
Volume1,561,810
Open248.85
Previous Close247.40
Day's Range244.34 - 249.67
52-Week Range220.90 - 281.16
Beta0.96
AnalystsBuy
Price Target285.86 (+15.8%)
Earnings DateOct 28, 2021

About SYK

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other me...

IndustryHealth Care Equipment & Supplies
Founded1941
CEOKevin Lobo
Employees43,000
Stock ExchangeNYSE
Ticker SymbolSYK
Full Company Profile

Financial Performance

In 2020, Stryker's revenue was $14.35 billion, a decrease of -3.58% compared to the previous year's $14.88 billion. Earnings were $1.60 billion, a decrease of -23.24%.

Financial Statements

Analyst Forecast

According to 30 analysts, the average rating for Stryker stock is "Buy." The 12-month stock price forecast is 285.86, which is an increase of 15.79% from the latest price.

Price Target
$285.86
(15.79% upside)
Analyst Consensus: Buy

News

Is This Powerhouse Medical Devices Stock a Buy?

Stryker is one of the largest medical device companies in the world, yet it appears to have plenty of growth left in the tank.

1 week ago - The Motley Fool

AHCO vs. SYK: Which Stock Should Value Investors Buy Now?

AHCO vs. SYK: Which Stock Is the Better Value Option?

Other symbols:AHCO
1 week ago - Zacks Investment Research

Stryker Launches New Prophecy Infinity Resect-Through Guides

MAHWAH, N.J.--(BUSINESS WIRE)--Stryker launched the Prophecy Infinity Resect-Through Guides for use in total ankle replacement surgeries.

2 weeks ago - Business Wire

Stryker (SYK) Earnings and Revenues Miss Estimates in Q3

Despite pandemic-led disruptions, Stryker's (SYK) third-quarter earnings reflect strong performance across Orthopaedics, MedSurg and Neurotechnology and Spine segments.

1 month ago - Zacks Investment Research

Stryker (SYK) Q3 Earnings and Revenues Lag Estimates

Stryker (SYK) delivered earnings and revenue surprises of -3.51% and -1.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Recap: Stryker Q3 Earnings

Stryker (NYSE:SYK) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

1 month ago - Benzinga

Stryker reports third quarter 2021 operating results

Kalamazoo, MI, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2021:

1 month ago - GlobeNewsWire

Stryker (SYK) to Report Q3 Earnings: What's in the Cards?

Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.

1 month ago - Zacks Investment Research

Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

2 Top Healthcare Stocks to Buy for the Long Haul

These two blue-chip healthcare stocks can help long-term investors sleep well at night.

Other symbols:CVS
1 month ago - The Motley Fool

Stryker to host analyst meeting

Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey.

1 month ago - GlobeNewsWire

This Stock Is Likely To Outperform Boston Scientific

We think that Stryker stock (NYSE: SYK) currently is a better pick compared to Boston Scientific stock, despite Stryker being slightly more expensive of the two. Stryker trades at about 6.4x trailing re...

1 month ago - Forbes

4 Stocks to Watch as Demand for Surgical Robots Ready to Rise

Watch out for the likes of Asensus Surgical (ASXC), Stryker (SYK), Medtronic (MDT) and Intuitive Surgical (ISRG) as demand for surgical robots is set to rise, owing to the conveniences they offer.

Other symbols:ASXCISRGMDT
2 months ago - Zacks Investment Research

Stryker to host conference call on October 28, 2021

Kalamazoo, Michigan, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company'...

2 months ago - GlobeNewsWire

5 Stocks to Deflect Delta Variant Curveball From Orthopedic Space

OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.

Other symbols:KIDSNUVAOFIXSPNEZBH
2 months ago - Zacks Investment Research

Stryker's (SYK) Trauma & Extremities Arm Unveils New Product

The newly launched Citrelock Tendon Fixation Device System expands Stryker's (SYK) Foot & Ankle offerings.

2 months ago - Zacks Investment Research

Stryker Launches New Tendon Fixation Device System

MAHWAH, N.J.--(BUSINESS WIRE)--Stryker's Trauma & Extremities division has launched its Citrelock™ Tendon Fixation Device System. The new system provides surgeons a differentiated design via a tendon th...

2 months ago - Business Wire

Stryker Corp: A Health Care Company You Shouldn't Ignore

Medical device companies are gradually seeing a rebound in their business as fewer elective medical visits, procedures and surgeries are being delayed due to Covid-19.

2 months ago - GuruFocus

Final Trades: Stryker, Editas Medicine, Oracle & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols:EDITORCL
2 months ago - CNBC Television

Stryker (SYK) Hits New 52-Week High: What's Driving It?

Investors are optimistic about Stryker's (SYK) strength in robotics and its diversified product portfolio.

2 months ago - Zacks Investment Research

Stryker Acquires Provider Of Blood Loss Monitoring Platform

Stryker Corporation (NYSE: SYK) has acquired Gauss Surgical for an undisclosed consideration. Gauss Surgical is a medical device company that has developed Triton, an artificial intelligence-enabled pla...

2 months ago - Benzinga

Here's Why You Should Retain Stryker (SYK) Stock Right Now

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure raises a concern.

3 months ago - Zacks Investment Research

Stuart F. Simpson is THINK Surgical's New President and Chief Executive Officer

FREMONT, Calif., Sept. 1, 2021 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Stuart F.

3 months ago - PRNewsWire

Stryker to participate in Morgan Stanley's 19th Annual Global Healthcare Conference

Kalamazoo, Michigan, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Morgan Stanley's 19th Annual Global Healthcare Conference on Monday, September 13, 2021.

3 months ago - GlobeNewsWire

Stryker Launches T2 Alpha Femur Retrograde Nailing System

MAHWAH, N.J.--(BUSINESS WIRE)--Stryker's T2 Alpha Femur Retrograde Nailing System features a redefined data-driven nail design, a dedicated proximal targeting system, and more.

3 months ago - Business Wire